Heartland Advisors Inc. Acquires 33,018 Shares of Teleflex Incorporated (NYSE:TFX)

Heartland Advisors Inc. grew its stake in shares of Teleflex Incorporated (NYSE:TFX) by 176.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 51,764 shares of the medical technology company’s stock after acquiring an additional 33,018 shares during the period. Heartland Advisors Inc. owned 0.11% of Teleflex worth $9,213,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. HighTower Advisors LLC increased its position in shares of Teleflex by 1.7% during the third quarter. HighTower Advisors LLC now owns 3,998 shares of the medical technology company’s stock worth $986,000 after buying an additional 66 shares during the period. Hengehold Capital Management LLC grew its holdings in Teleflex by 7.3% during the 4th quarter. Hengehold Capital Management LLC now owns 1,289 shares of the medical technology company’s stock worth $229,000 after acquiring an additional 88 shares during the period. Exchange Traded Concepts LLC raised its position in shares of Teleflex by 38.2% in the 4th quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company’s stock worth $61,000 after acquiring an additional 94 shares in the last quarter. Isthmus Partners LLC lifted its stake in shares of Teleflex by 7.3% in the 4th quarter. Isthmus Partners LLC now owns 1,535 shares of the medical technology company’s stock valued at $273,000 after purchasing an additional 105 shares during the period. Finally, Sumitomo Mitsui DS Asset Management Company Ltd boosted its position in shares of Teleflex by 2.4% during the 4th quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 4,991 shares of the medical technology company’s stock valued at $888,000 after purchasing an additional 118 shares in the last quarter. 95.62% of the stock is currently owned by institutional investors.

Teleflex Stock Down 0.6 %

TFX opened at $139.34 on Friday. Teleflex Incorporated has a fifty-two week low of $128.55 and a fifty-two week high of $249.91. The firm has a market capitalization of $6.46 billion, a P/E ratio of 27.70, a PEG ratio of 1.73 and a beta of 1.21. The company’s 50-day moving average is $160.07 and its 200 day moving average is $191.50. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39.

Teleflex (NYSE:TFX) last issued its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, topping analysts’ consensus estimates of $3.86 by $0.03. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The company had revenue of $795.40 million for the quarter, compared to the consensus estimate of $813.24 million. Research analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Friday, March 7th were issued a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 0.98%. The ex-dividend date was Friday, March 7th. Teleflex’s dividend payout ratio (DPR) is presently 95.77%.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on TFX shares. StockNews.com lowered Teleflex from a “buy” rating to a “hold” rating in a research note on Friday, February 28th. Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a research note on Wednesday, March 12th. Truist Financial decreased their price target on shares of Teleflex from $200.00 to $149.00 and set a “hold” rating for the company in a research note on Monday, March 3rd. Morgan Stanley cut their price objective on shares of Teleflex from $275.00 to $191.00 and set an “overweight” rating on the stock in a research report on Wednesday, March 5th. Finally, Raymond James lowered Teleflex from an “outperform” rating to a “market perform” rating in a research report on Friday, February 28th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $182.63.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.